155 related articles for article (PubMed ID: 16802352)
1. Clinical images: B cell depletion in the appendix following rituximab treatment.
Paran D; Trej'o L; Caspi D
Arthritis Rheum; 2006 Jul; 54(7):2151. PubMed ID: 16802352
[No Abstract] [Full Text] [Related]
2. Rituximab, B-lymphocyte depletion, and beta-cell function.
Nagafuchi S; Katsuta H; Anzai K
N Engl J Med; 2010 Feb; 362(8):761; author reply 761. PubMed ID: 20181981
[No Abstract] [Full Text] [Related]
3. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
4. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
5. Role of rituximab therapy in glomerulonephritis.
Jayne D
J Am Soc Nephrol; 2010 Jan; 21(1):14-7. PubMed ID: 18799717
[TBL] [Abstract][Full Text] [Related]
6. Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.
Huggins JL; Brunner HI
J Pediatr; 2006 May; 148(5):571-3. PubMed ID: 16737861
[No Abstract] [Full Text] [Related]
7. Rituximab: a B-cell depletion therapy for dermatologic disease.
Prajapati V; Mydlarski PR
Skin Therapy Lett; 2007; 12(6):6-9. PubMed ID: 17762903
[TBL] [Abstract][Full Text] [Related]
8. Development of psoriasis after B cell depletion with rituximab.
Dass S; Vital EM; Emery P
Arthritis Rheum; 2007 Aug; 56(8):2715-8. PubMed ID: 17665440
[TBL] [Abstract][Full Text] [Related]
9. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
[TBL] [Abstract][Full Text] [Related]
10. Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus.
Suzuki K; Nagasawa H; Kameda H; Amano K; Kondo T; Itoyama S; Tanaka Y; Takeuchi T
Rheumatology (Oxford); 2009 Feb; 48(2):198-9. PubMed ID: 19029134
[No Abstract] [Full Text] [Related]
11. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus.
Podolskaya A; Stadermann M; Pilkington C; Marks SD; Tullus K
Arch Dis Child; 2008 May; 93(5):401-6. PubMed ID: 18039744
[TBL] [Abstract][Full Text] [Related]
12. Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases.
Lu TY; Jónsdóttir T; van Vollenhoven RF; Isenberg DA
Ann Rheum Dis; 2008 Oct; 67(10):1493-4. PubMed ID: 18791057
[No Abstract] [Full Text] [Related]
13. Six refractory lupus patients treated with rituximab: a case series.
Gillis JZ; Dall'era M; Gross A; Yazdany J; Davis J
Arthritis Rheum; 2007 Apr; 57(3):538-42. PubMed ID: 17394185
[No Abstract] [Full Text] [Related]
14. New therapies for systemic lupus erythematosus: cellular targets.
Looney RJ; Anolik J; Sanz I
Rheum Dis Clin North Am; 2006 Feb; 32(1):201-15, xi. PubMed ID: 16504831
[TBL] [Abstract][Full Text] [Related]
15. Drug insight: rituximab in renal disease and transplantation.
Salama AD; Pusey CD
Nat Clin Pract Nephrol; 2006 Apr; 2(4):221-30. PubMed ID: 16932428
[TBL] [Abstract][Full Text] [Related]
16. Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?
Hertl M; Eming R; Borradori L
Dermatology; 2007; 214(4):275-7. PubMed ID: 17460396
[No Abstract] [Full Text] [Related]
17. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I
Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
[TBL] [Abstract][Full Text] [Related]
18. Clonal expansion of B-cells in human systemic lupus erythematosus: evidence from studies before and after therapeutic B-cell depletion.
Sfikakis PP; Karali V; Lilakos K; Georgiou G; Panayiotidis P
Clin Immunol; 2009 Jul; 132(1):19-31. PubMed ID: 19345151
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in lupus and beyond: the state of the art.
Hughes G
Lupus; 2009 Jun; 18(7):639-44. PubMed ID: 19433465
[No Abstract] [Full Text] [Related]
20. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
Vallerskog T; Gunnarsson I; Widhe M; Risselada A; Klareskog L; van Vollenhoven R; Malmström V; Trollmo C
Clin Immunol; 2007 Jan; 122(1):62-74. PubMed ID: 17046329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
